Viewing Study NCT02607735


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-01-05 @ 5:46 PM
Study NCT ID: NCT02607735
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2015-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy
Sponsor: Gilead Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-11-11
Start Date Type: ACTUAL
Primary Completion Date: 2016-10-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-06-21
Completion Date Type: ACTUAL
First Submit Date: 2015-11-16
First Submit QC Date: None
Study First Post Date: 2015-11-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-10-04
Results First Submit QC Date: None
Results First Post Date: 2017-12-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-02-08
Last Update Post Date: 2019-03-05
Last Update Post Date Type: ACTUAL